Product screen
Reviewer Console
Screenshot-ready product surface for enterprise review.
Reviewer queuePending translational sign-off
| Reviewer | Area | Status | Comment |
|---|---|---|---|
| Clinical Reviewer | Trial evidence | Signed | Evidence classification accepted |
| Oncology Reviewer | Biomarker rationale | Signed | Proceed to memo draft |
| Translational Reviewer | Comparator context | Pending | Review Sotorasib comparison |
Decision memoLocked until approval
Rationale: KRAS G12C evidence supports progression to biomarker strategy review.
Risks: Comparator evidence and resistance context require final reviewer sign-off.
Lineage completeVersion v0.9Audit export ready